Fagron NV (EBR:FAGR)
22.45
-0.30 (-1.32%)
Mar 2, 2026, 2:42 PM CET
Fagron NV Revenue
In the year 2025, Fagron NV had annual revenue of 952.17M EUR with 9.20% growth. Fagron NV had revenue of 476.04M in the half year ending December 31, 2025, with 21.62% growth.
Revenue
952.17M
Revenue Growth
+9.20%
P/S Ratio
1.75
Revenue / Employee
238.70K
Employees
3,989
Market Cap
1.67B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 952.17M | 80.21M | 9.20% |
| Dec 31, 2024 | 871.96M | 108.97M | 14.28% |
| Dec 31, 2023 | 762.99M | 79.11M | 11.57% |
| Dec 31, 2022 | 683.88M | 110.07M | 19.18% |
| Dec 31, 2021 | 573.81M | 17.84M | 3.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UCB SA | 7.74B |
| argenx SE | 3.62B |
| Ion Beam Applications | 585.76M |
| European Medical Solutions | 49.47M |
| Hyloris Pharmaceuticals | 8.46M |
| Nyxoah | 5.64M |
| Onward Medical | 2.72M |
| Celyad Oncology | 186.00K |
Fagron NV News
- 13 days ago - Fagron NV (ARSUF) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 14 days ago - Full Year 2025 Fagron NV Earnings Call Transcript - GuruFocus
- 17 days ago - Fagron NV 2025 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 3 months ago - Pharma 5.0 delivers personalized treatment using AI, says Fagron CEO - CNBC
- 3 months ago - Fagron Announces Acquisitions Of Amara And Magilab - Nasdaq
- 4 months ago - Half Year 2025 Fagron NV Earnings Call Transcript - GuruFocus
- 5 months ago - Fagron NV (ARSUF) Q3 2025 Sales Call Transcript - Seeking Alpha
- 5 months ago - Fagron NV (ARSUF) Q3 2025 Sales/ Trading Statement Call - Slideshow - Seeking Alpha